“…Compound 111 ((5 R ,10 S ,16 R )-11,16,19-trihydroxy-12-O-β-D-glucopyranosyl-(1→2)-β-D-glucopyranosyl-17(15→16),18(4→3)- diabeo -3,8,11,13-abietatetraene-7-one) inhibited these enzymes activity with an IC 50 value of 18.5 and 24.6 µM, respectively. (5R,10S,16R)-11,16-dihydroxy-12-O-β-D-glucopyranosyl-(1→2)-β-D-glucopyranosyl-17(15→16),18(4→3)- diabeo -4-carboxy-3,8,11,13-abietatetraene-7-one demonstrated weaker activity (IC 50 = 64.6 and 78.3 µM) [ 76 ]. Additionally, the studied compounds were tested for acethyl- and buthyrylcholinesterase (AChE and BChE) inhibition, showing weak activity against AChE with an IC 50 of 191 and 139 µM, respectively [ 76 ].…”